| Mr Michael Brendan Cloney, BA | |
|
240 E Huron St, Suite 1-203, Chicago, IL 60611-2909 | |
| (847) 340-3927 | |
| Not Available |
| Full Name | Mr Michael Brendan Cloney |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 240 E Huron St, Chicago, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164885000 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 125069488 (Illinois) | Primary |
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
San Francisco's Board of Supervisors is slated to vote Tuesday to ban the sale and distribution of e-cigarettes in the city. The city is the corporate home of Juul Labs, the biggest producer of e-cigarettes in the country.
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it has been included on a list of preliminary additions to the Russell 3000® Index, the Russell Microcap® Index and the Russell Global® Index posted by Russell Investments on June 11, 2010 on www.russell.com.
A dietary supplement manufacturer and two of its executives have been ordered by a federal court to stop manufacturing, holding, or distributing any articles of food, including dietary supplements, until they come into compliance with federal dietary supplement current good manufacturing practice regulations and other Federal Food, Drug, and Cosmetic Act (FD&C Act) requirements.
British scientists have identified a protein in urine that can help indicate which patients are at an increased risk of developing prostate cancer. The Cancer Research UK Cambridge Research Institute and The Institute of Cancer Research found that the level of MSMB protein in urine could provide a fast and accurate prostate cancer diagnosis for doctors and patients, potentially replacing the currently painful and more costly approach a blood sample.
Using a newly discovered cell technology, Georgetown University Medical Center researchers were able to identify an effective therapy for a patient with a rare type of lung tumor. The single case study, reported in the September 27 issue of New England Journal of Medicine, provides a snapshot of the new technology's promising potential; however, researchers strongly caution that it could be years before validation studies are completed and regulatory approval received for its broader use.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Michael Brendan Cloney, BA 240 E Huron St, Suite 1-203, Chicago, IL 60611-2909 Ph: () - | Mr Michael Brendan Cloney, BA 240 E Huron St, Suite 1-203, Chicago, IL 60611-2909 Ph: (847) 340-3927 |
News Archive
San Francisco's Board of Supervisors is slated to vote Tuesday to ban the sale and distribution of e-cigarettes in the city. The city is the corporate home of Juul Labs, the biggest producer of e-cigarettes in the country.
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it has been included on a list of preliminary additions to the Russell 3000® Index, the Russell Microcap® Index and the Russell Global® Index posted by Russell Investments on June 11, 2010 on www.russell.com.
A dietary supplement manufacturer and two of its executives have been ordered by a federal court to stop manufacturing, holding, or distributing any articles of food, including dietary supplements, until they come into compliance with federal dietary supplement current good manufacturing practice regulations and other Federal Food, Drug, and Cosmetic Act (FD&C Act) requirements.
British scientists have identified a protein in urine that can help indicate which patients are at an increased risk of developing prostate cancer. The Cancer Research UK Cambridge Research Institute and The Institute of Cancer Research found that the level of MSMB protein in urine could provide a fast and accurate prostate cancer diagnosis for doctors and patients, potentially replacing the currently painful and more costly approach a blood sample.
Using a newly discovered cell technology, Georgetown University Medical Center researchers were able to identify an effective therapy for a patient with a rare type of lung tumor. The single case study, reported in the September 27 issue of New England Journal of Medicine, provides a snapshot of the new technology's promising potential; however, researchers strongly caution that it could be years before validation studies are completed and regulatory approval received for its broader use.
› Verified 6 days ago
Peleg Horowitz, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Stephen Ondra, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-695-9797 | |
Adam Mendel Sonabend Worthalter, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 675 N Saint Clair St Ste 21-100, Chicago, IL 60611 Phone: 312-695-0990 | |
Kazuki Sakakura, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 600 S Paulina St, Chicago, IL 60612 Phone: 628-628-6309 | |
Gail L Rosseau, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 4501 N Winchester Ave, 2nd Fl, Chicago, IL 60640 Phone: 773-250-0500 Fax: 773-250-0497 | |
Dr. Ravi Nunna, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1650 W Harrison St Ste 466, Chicago, IL 60612 Phone: 312-942-5495 | |
Tord Alden, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 2300 N Childrens Plz, Chicago, IL 60614 Phone: 773-880-4000 Fax: 773-281-1576 |